ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. (Q53627379)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins.	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

ERK1/2 promoted proliferation and inhibited apoptosis of human cervical cancer cells and regulated the expression of c-Fos and c-Jun proteins. (English)

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

cervix uterine cancer

1 reference

based on heuristic

inferred from title

author name string

Lixia Bai

1

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Rui Mao

2

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Jintao Wang

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Ling Ding

4

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Shiwen Jiang

5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Chenfei Gao

6

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Huijie Kang

7

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Xiao Chen

8

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Xuesong Sun

9

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Juan Xu

10

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

publication date

3 February 2015

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Medical Oncology

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

32

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

3

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

57

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Axl kinase as a key target for oncology: focus on small molecule inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Emerging molecular targets in oncology: clinical potential of MET/hepatocyte growth-factor inhibitors

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Small molecule inhibitors of the hedgehog signaling pathway for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

MEK1/2 inhibitors in the treatment of gynecologic malignancies.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

The extracellular signal-regulated kinase: multiple substrates regulate diverse cellular functions

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

ERK1/2 MAP kinases: structure, function, and regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Thymoquinone-induced conformational changes of PAK1 interrupt prosurvival MEK-ERK signaling in colorectal cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Overexpression of HepaCAM inhibits cell viability and motility through suppressing nucleus translocation of androgen receptor and ERK signaling in prostate cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

ERKs in cancer: friends or foes?

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

C/EBP alpha:AP-1 leucine zipper heterodimers bind novel DNA elements, activate the PU.1 promoter and direct monocyte lineage commitment more potently than C/EBP alpha homodimers or AP-1

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

AP-1 as a regulator of cell life and death

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Targeting the MAPK-RAS-RAF signaling pathway in cancer therapy

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Phenethyl isothiocyanate sensitizes human cervical cancer cells to apoptosis induced by cisplatin

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Phase I and pharmacodynamic study of the oral MEK inhibitor CI-1040 in patients with advanced malignancies

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Multicenter phase II study of the oral MEK inhibitor, CI-1040, in patients with advanced non-small-cell lung, breast, colon, and pancreatic cancer

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Phase I pharmacokinetic and pharmacodynamic study of the oral MAPK/ERK kinase inhibitor PD-0325901 in patients with advanced cancers

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Biological characterization of ARRY-142886 (AZD6244), a potent, highly selective mitogen-activated protein kinase kinase 1/2 inhibitor

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

AP-1 subunits: quarrel and harmony among siblings

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Constitutive activation of transcription factor AP-1 in cervical cancer and suppression of human papillomavirus (HPV) transcription and AP-1 activity in HeLa cells by curcumin.

1 reference

https://api.crossref.org/works/10.1007%2FS12032-015-0490-5

21 January 2018

Risk factors for cervical cancer in rural areas of Wuhan China: a matched case-control study

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Targeting the PI3K/mTOR Pathway in Pediatric Hematologic Malignancies.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Epidemiology and risk factors for cancer of the uterus]

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiac hormones target nuclear oncogenes c-Fos and c-Jun in carcinoma cells

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Close correlation between MEK/ERK and Aurora-B signaling pathways in sustaining tumorigenic potential and radioresistance of gynecological cancer cell lines.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Insulin promotes proliferation and migration of breast cancer cells through the extracellular regulated kinase pathway.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Claudin-7 inhibits human lung cancer cell migration and invasion through ERK/MAPK signaling pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/25647783

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12032-015-0490-5

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

16 May 2018

http://europepmc.org/abstract/MED/25647783

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q53627379&oldid=2212235769"